Moderna’s COVID-19 vaccine: 5 things you need to know

{ object.primary_image.title }}

Early signs are encouraging, but we need to let the science take its time and not get our hopes too high yet. Last week the world got a big dose of promising news: Pharma giant Pfizer announced early results showing its COVID-19 vaccine was effective in more than 90% of the people who received it. This week is also getting off to a good start. American biotech giant Moderna has now announced that its own COVID-19 vaccine is effective in 94.5% of the people who received it, reports The Wall Street Journal . Here’s what you need to know: Read Full Story

Read Full Article on Fast Company

Oxford COVID-19 vaccine: Not as effective, but better than other vaccines in two big ways

{ object.primary_image.title }}

The effacacy of the Oxford vaccine is relatively low compared to Moderna’s and Pfizer’s—but it has two major advantages over its competitors. Another week and more good news in the fight against COVID-19. For the third week in a row, a successful COVID-19 has been announced—this time from researchers at Oxford University in the United Kingdom, reports the BBC. The Oxford vaccine has been one of the longest in the making—work began almost 10 months ago. However, the Oxford vaccine has a major drawback versus the American vaccines, but it also has two major advantages. Here’s what you need to know. Read Full Story

More

Sorry, the COVID-19 vaccine won’t make life go back to normal right away

{ object.primary_image.title }}

If you were hoping that the new COVID-19 vaccines could make it possible to stop wearing masks and social distancing, think again. Pfizer’s new COVID-19 vaccine might get FDA emergency use authorization in a few weeks, and a small group of Americans might begin getting shots in December. Moderna’s vaccine might quickly follow. But even for those who can get vaccinated soon—potentially 20 million people in the U.S., out of a population of more than 320 million—life won’t be able to go back to normal yet. Read Full Story

More

Moderna chief medical officer: Vaccinated adults could still infect the unvaccinated with COVID-19

{ object.primary_image.title }}

The vaccines ‘do not show that they prevent you from potentially carrying this virus . . . and infecting others.’ We’ve gotten three incredibly good pieces of news in as many weeks when it comes to the COVID-19 pandemic. Each of the last three weeks saw the announcement that another SARS-CoV-2 vaccine has shown promising results and is waiting on regulatory approval so distribution can begin. For some, like front-line healthcare workers, the vaccine could be delivered as early as December. But for most, it’ll be late spring to summer before the mass rollout of vaccinations begins. Yet even then, things may not “get back to normal” as quickly as we’re all hoping it would once a vaccine became available. Read Full Story

More

Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing

{ object.primary_image.title }}

Albert Bourla talks about his employees’ effort to develop a COVID-19 vaccine in record time, Pfizer’s friendly rivalry with Moderna, and what’s next for the pharmaceutical giant. To mark the year since the World Health Organization declared COVID-19 a global pandemic, Pfizer CEO Albert Bourla penned an open letter , reflecting on a year of loss and discovery. He praised his employees and the pharmaceutical industry for its ability to innovate and collaborate. (Pfizer and Germany’s BioNTech received the first authorization for a COVID-19 vaccine in December 2020.) Read Full Story

More

This handy state-by-state COVID vaccine planner lets you see when you can get your shot

{ object.primary_image.title }}

Comcast NBCUniversal has launched a new website to help people find exactly what they need to know about getting the vaccine in their own state. Information about the COVID-19 vaccine is coming at us fast and furiously. Updates about availability, eligibility, and other factors determine who can get it soon and who has to wait. Multiply that out by 50, because each state is handling their own vaccine distribution. Read Full Story

More

Pfizer COVID-19 vaccine update: Final results show it’s now 95% effective

{ object.primary_image.title }}

But don’t let your COVID-19 guard down yet. There’s still a long way to go before most people will receive the vaccine. Earlier this month, pharmaceutical giant Pfizer gave us some of the best news all year : Their COVID-19 vaccine was found to be effective in more than 90% of the people who received it. However, that news was preliminary, and the company was waiting on further results to see if the efficacy rating held. Read Full Story

More

Moderna is testing a COVID-19 vaccine on humans. This is what they’re not telling you

{ object.primary_image.title }}

Moderna reported positive Phase I testing results for its COVID-19 vaccine and will begin Phase III testing it on 30,000 humans in two weeks. News! Moderna reported positive Phase I testing results for its COVID-19 vaccine and will begin Phase III testing it on 30,000 humans in two weeks. (Separate Phase II trials are underway.) “No matter how you slice this, this is good news,” Dr. Anthony Fauci, our national bearer of bad news, told the Associated Press. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=11465, ajax_url='/api/hit/ajax/', hits='3')